Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials
Theresa Hunter, Marina Magrey, Martín Rudwaleit, Jeffrey Lisse et al.
Journal
Rheumatology and Therapy
Topics
Spondyloarthritis Studies and Treatments
article
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials
Theresa Hunter, Marina Magrey, Martín Rudwaleit, Jeffrey Lisse, Khai Jing Ng, Andris Kronbergs, Proton Rahman, John D. Reveille, Victoria Navarro‐Compán, José A. Maldonado‐Cocco, Rebecca Bolce, So Young Park
article en
Abstract
No abstract available for this paper.
Publication Tag
Rheumatology and TherapyVol. 13(1)
Institutions
Memorial University of Newfoundland (CA), Eli Lilly (United States) (US), Universidad de Buenos Aires (AR), Klinikum Bielefeld (DE), University School (US), The University of Texas Health Science Center (US), Case Western Reserve University (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials — Theresa Hunter, Marina Magrey, et al. · Rheumatology and Therapy (2025) | TGRS Research Map | TGRS